Home > News > Disease diagnosis, drug development focus of UH prof's biochip research
September 1st, 2004
Disease diagnosis, drug development focus of UH prof's biochip research
Abstract:
Leading the way to disease diagnosis and drug development, biochip research at the University of Houston will be presented to an international audience of top nanoscientists next week. B. Montgomery Pettitt, the Hugh Roy and Lillie Cranz Cullen Distinguished Professor of Chemistry at the University of Houston, has been selected as one of the plenary speakers at the Pacific Rim Nanoscience Conference Sept. 7-11 in Broome, Western Australia. Pettitt is one of only three American scientists among the 21 invited speakers.
Source:
medicalnewstoday
Bookmark:
| Related News Press |
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Announcements
Rice membrane extracts lithium from brines with greater speed, less waste October 3rd, 2025
Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
Next-generation quantum communication October 3rd, 2025
"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||